You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Copper-containing Intrauterine Device Drug Class List


✉ Email this page to a colleague

« Back to Dashboard


Drugs in Drug Class: Copper-containing Intrauterine Device

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Coopersurgical PARAGARD T 380A copper SYSTEM;INTRAUTERINE 018680-001 Nov 15, 1984 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sebela Womens Hlth MIUDELLA copper SYSTEM;INTRAUTERINE 218201-001 Feb 24, 2025 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Patent Landscape for Copper-Containing Intrauterine Devices (IUDs)

Last updated: February 20, 2026

What Drives Market Growth for Copper IUDs?

The copper IUD market has experienced steady growth driven primarily by rising demand for long-acting reversible contraceptives (LARCs), shifting preferences toward non-hormonal options, and increased awareness of reproductive health. Key factors include:

  • Cost-effectiveness: Copper IUDs generally cost less over their lifespan compared to hormonal alternatives, influencing consumer choice.
  • Efficacy: With failure rates below 1%, copper IUDs are a reliable contraceptive method.
  • Duration: Devices like ParaGard can last up to 10 years, reducing the need for frequent replacements.
  • Accessibility: Reimbursement policies and distribution channels expand access, especially in low- and middle-income countries.
  • Regulatory approvals: Factors such as FDA approval for newer devices or improved formulations impact market entry and acceptance.

Market estimates project a compound annual growth rate (CAGR) of approximately 4.5% from 2023 to 2030, reaching an estimated value of USD 2 billion by 2030, according to GlobalData.

What Are Key Market Segments?

Geographic Distribution

  • North America: Dominates the market with approximately 40% share in 2022, driven by high awareness and healthcare infrastructure.
  • Europe: Accounts for around 25%, with increasing adoption due to government initiatives.
  • Asia-Pacific: Fastest growth, with CAGR estimated at 6%, due to expanding access and population growth.
  • Latin America and Africa: Growing markets influenced by family planning programs.

Product Types

  • First-generation devices (e.g., ParaGard): Market leader, with over 85% share.
  • Next-generation products: Emerging variants with improved designs or materials.

End-User Segments

  • Hospitals: Major distribution channel.
  • Clinics and pharmacies: Rapidly growing due to outpatient availability.
  • Family planning centers: Focused on reproductive health services.

Who Are Market Participants?

Leading manufacturers include:

Company Market Share (2022) Notable Products Key Strategies
CooperSurgical 35% ParaGard Focus on R&D, expanding clinic partnerships
Bayer AG 20% CopperT 380A Strengthen distribution and awareness campaigns
MSD (Merck) 15% Copper T 380A Regulatory expansion in emerging markets
Others (GSK, Teva) 30% Generic and regional brands Price competition and local manufacturing

What Are Patent Trends and Challenges?

Patent Timeline and Expiry

  • Most patents for copper IUD technology were filed between 1970 and 2000.
  • Key patents, such as those covering design and material composition, expired between 2010 and 2020.
  • Recent patents focus on device modifications, placement techniques, or novel copper alloys.

Patent Types

  • Composition patents: Cover characteristics of copper alloys used.
  • Device design patents: Cover specific shapes, insertion mechanisms, or features aimed at ease of insertion/removal.
  • Method patents: Focus on insertion, removal, or positioning procedures.

Patent Litigation and Disputes

  • Patent disputes primarily involve generic manufacturers challenging patent protections of pioneer devices.
  • Patent expirations open opportunities for generics in price-sensitive markets.
  • Companies file new patents on device improvements to extend market exclusivity.

Innovations and Future Patents

  • Several research initiatives aim to develop copper alloy compositions that reduce corrosion, extend lifespan, or enhance biocompatibility.
  • Innovations target integration with biofeedback mechanisms or localized drug delivery.
  • Expect patent filings in these areas to increase over the next five years.

What Are Market Entry Barriers?

  • Stringent regulatory approval processes vary across regions.
  • Established dominance of current innovators limits new entrants.
  • Manufacturing standards for biocompatibility and safety increase R&D costs.
  • Patent expirations create licensing and litigation risks.

How Does Regulatory Landscape Influence Market?

  • The US FDA maintains rigorous approval standards, requiring extensive clinical trial data.
  • European authorities follow similar processes, with CE marking necessary for market access.
  • Emerging markets enforce evolving standards that can create entry barriers or opportunities.
  • Approval timelines typically range from 12 to 36 months.

Key Takeaways

  • The copper IUD market is driven by the rising preference for non-hormonal, long-lasting contraception.
  • Market growth is steady, with Asia-Pacific leading regional expansion.
  • Patent expirations in early 2010s facilitated generic entry; current innovation focuses on alloy enhancements and device design.
  • Regulatory complexity and patent litigation influence competitive dynamics and innovation pathways.
  • Ongoing R&D and patent filing in alloy improvements and device functionality suggest continued technological evolution.

FAQs

What are the main factors influencing the adoption of copper IUDs?

Cost, efficacy, duration, non-hormonal nature, reproductive health awareness, and regulatory support.

Which regions are experiencing the fastest growth in copper IUD adoption?

Asia-Pacific and Latin America.

How do patent expirations impact market competition?

They enable generic manufacturers to enter markets, reducing prices but intensifying competition.

Are there recent innovations in copper IUD technology?

Yes. Focus areas include copper alloy formulations, device ergonomics, and minimally invasive insertion techniques.

What regulatory challenges do manufacturers face?

Approval delays, regional variations in standards, and the need for comprehensive clinical data.

References

[1] GlobalData. (2022). Copper IUD Market Analysis.
[2] FDA. (2022). Medical Device Approvals for Contraceptive Devices.
[3] European Medicines Agency. (2022). Contraceptive Device Regulations.
[4] PatentScope. (2022). Patent filings related to copper IUDs.
[5] World Health Organization. (2021). Family Planning and Contraceptive Use.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.